Gut Microbiota and Adolescent Depression: From Root Causes to Emerging Treatments

Adolescent depression is a rising crisis, with rates increasing steadily over the past decade. It is a leading cause of disability among youth aged 10 to 24 in the United States and poses a growing global public health challenge.

Despite the urgency, traditional treatments like behavioral therapy and medication, while still essential, fall short for many adolescents. Antidepressants, for instance, often the first line of pharmacologic therapy, show reduced effectiveness in youth compared to adults due to age-related biological differences.

Researchers have found that the connection between gut health and mental well-being offers a promising new frontier.

This IPA blog explores how gut microbiota and the brain interact during adolescence and highlights emerging evidence that psychobiotics may offer a new complementary tool for reducing risk for and managing depression during this sensitive developmental window.

Adolescent brain development and depression

Adolescence—age 10 to 24 years— is a critical period of brain development marked by rapid neural changes and heightened vulnerability to stress, poor nutrition, sleep disruption, and risky behaviors. Alongside the neonatal stage, it represents one of the most dynamic phases of brain growth. During this pivotal period of frontolimbic brain development, responsible for emotional regulation and reward processing, depression may often begin to emerge.

Stress and hormonal changes during this time can disrupt neurodevelopment, increasing long-term vulnerability to depression.

During adolescence, the Hypothalamic-Pituitary-Adrenal (HPA) axis plays a central role in shaping frontolimbic brain regions, making this period especially susceptible to the effects of stress. Chronic stress can dysregulate the HPA axis, leading to excessive glucocorticoid signaling (e.g., cortisol) that disrupts frontolimbic development. These neurobiological changes, intensified by pubertal hormones, help explain why disorders like depression can emerge and persist during this critical window.

The adolescent gut-brain axis

The gut-brain axis, a bidirectional communication system linking the gut and central nervous system, plays a vital role in shaping the adolescent brain. During this critical period of neurodevelopment, the gut microbiota also matures, with changes in microbial diversity correlating with brain development.

Through two-way signaling, the brain regulates gut function via the HPA axis and autonomic nervous system, while the gut communicates back through microbial metabolites, hormones, and neuroactive compounds. For example, short-chain fatty acids (SCFAs) produced by microbial fermentation help maintain gut integrity and influence mood and cognition by modulating neuroinflammation and neurotransmitter activity.

Microbial disruption and depression risk

Microbial signals during critical periods such as adolescence are thought to play a vital role in shaping lifelong communication along the gut-brain axis. When gut-brain communication is disrupted, such as through dysbiosis, regulatory mechanisms can become unbalanced. For example, stress-induced norepinephrine can encourage pathogen growth, while reduced SCFA production may impair brain signaling, increasing vulnerability to frontolimbic dysfunction and increasing the risk for depression in adolescence, as well as other neurodevelopmental disorders not discussed here.

A 2022 review highlights that stress-induced changes in the gut microbiota can destabilize the HPA axis, creating a pathway through which stress contributes to long-term dysregulation and impaired development of frontolimbic brain regions, heightening vulnerability to depression during adolescence.

Both animal and human studies suggest that such microbiota changes can impact neurodevelopmental pathways related to the stress response, myelination, and emotional regulation.

Depression is consistently associated with shifts in gut microbial composition, including increases in pro-inflammatory taxa like Eggerthella and Streptococcus, and decreases in anti-inflammatory, butyrate-producing genera such as Faecalibacterium and Coprococcus. While some variability exists across studies, these changes suggest a disrupted microbial balance that may contribute to inflammation and altered brain function in depression. In one study, transplanting fecal microbiota from patients with major depressive disorder to adolescent rats induced depressive-like behaviors and reduced 14 amino acids in the prefrontal cortex.

Probiotic intervention studies

Emerging evidence suggests that targeting the microbiota in early life or adolescence—but not adulthood—can reverse stress-induced brain and behavioral deficits. This suggests a developmentally limited window of plasticity and points to the gut microbiota as a promising target for reducing the risk for adolescent-onset depression.

Animal studies

Many animal studies suggest that adolescence is a key period during which probiotic therapy can reduce the risk for long-term stress-induced changes to the gut microbiota, HPA axis, and behavior.

In adolescent rodents exposed to stress, probiotics reduced anxiety- and depression-like behaviors. They also normalized stress hormone levels and restored neurochemical balance in mood-related brain regions. Multiple mechanisms are thought to be at play in probiotic effects on depressive symptoms in animal studies. These include restoring gut microbial balance, lowering inflammation, strengthening the intestinal barrier, restoring the production of key microbial metabolites and neurotransmitters (e.g., serotonin, dopamine), and sending regulatory signals that dampen HPA-axis hyperactivity. Together, these effects support healthy brain development and emotional regulation during adolescence.

Human studies

Clinical trials suggest that probiotics may offer modest short-term benefits in reducing depressive symptoms in adults with major depressive disorder, including those with treatment-resistant depression. However, findings remain inconsistent due to variations in study design, strains, dosages, and outcome measures, making overall support equivocal.

No studies to date have focused exclusively on probiotic therapy in adolescents with depression.

Nevertheless, preliminary trials suggest that Lactobacillus-containing probiotics may help in the management of stress-induced HPA-axis hyperactivity and reduce anxiety and depressive symptoms in non-clinical youth (young individuals without diagnosed mental health disorders). For example, one study found that a specific strain of Lacticaseibacillus casei inhibited increases in salivary cortisol and altered gut microbiota composition in healthy medical students (older adolescents and young adults) under exam stress. Another study showed that a strain of Lactobacillus gasseri improved depressive symptoms, anxiety, and sleep quality in a similar population. These findings highlight the potential for certain probiotic strains to help manage stress-related physiological and psychological responses in healthy young adults.

Prebiotic & synbiotic intervention studies

Evidence on prebiotic and synbiotic therapy for depression is limited and mixed, with animal studies suggesting that prebiotics like fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS) may indirectly improve depressive symptoms by promoting beneficial gut bacteria and reducing inflammation, while human trials have yielded inconsistent results, especially when prebiotics are used alone.

When able to produce a health benefit in patients suffering from mental illness, biotics are increasingly called psychobiotics. Integrating psychobiotics into adolescent mental health care holds potential promise, particularly when used with other treatments, tailored to the individual, or started early. Future research should focus on expanding knowledge in this specific age group to explore how individual microbiota profiles can guide these interventions.

Takeaway

Adolescent depression is a growing public health crisis, with additional support required beyond traditional treatments like therapy and medication. Growing evidence points to the gut-brain axis as a key player in its development. Stress and hormonal changes during puberty can influence both brain development and gut microbiota and may contribute to frontolimbic dysfunction and heightened adolescent depression risk.

Research shows that targeting the gut microbiota during adolescence—when both the brain and gut are still maturing—may offer a window of opportunity for reducing this risk. Animal and preliminary human studies suggest that specific probiotic strains, often referred to as psychobiotics, can help reduce stress-induced changes, support emotional regulation, and potentially help manage depressive symptoms. While more research is needed, especially in adolescents, early and personalized psychobiotic strategies could complement traditional treatments and improve mental health outcomes for youth at risk.

Image by kp yamu Jayanath from Pixabay

Key references

Alli, Sauliha R et al. “The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies.” International journal of molecular sciences vol. 23,9 4494. 19 Apr. 2022, doi:10.3390/ijms23094494

Bambury, Aisling et al. “Finding the needle in the haystack: systematic identification of psychobiotics.” British journal of pharmacology vol. 175,24 (2018): 4430-4438. doi:10.1111/bph.14127

Cowan, Caitlin S M et al. “Annual Research Review: Critical windows – the microbiota-gut-brain axis in neurocognitive development.” Journal of child psychology and psychiatry, and allied disciplines vol. 61,3 (2020): 353-371. doi:10.1111/jcpp.13156

Davey, Christopher G et al. “The emergence of depression in adolescence: development of the prefrontal cortex and the representation of reward.” Neuroscience and biobehavioral reviews vol. 32,1 (2008): 1-19. doi:10.1016/j.neubiorev.2007.04.016

Dinan, Timothy G et al. “Psychobiotics: a novel class of psychotropic.” Biological psychiatry vol. 74,10 (2013): 720-6. doi:10.1016/j.biopsych.2013.05.001

Flannery, Jessica et al. “Is adolescence the missing developmental link in Microbiome-Gut-Brain axis communication?.” Developmental psychobiology vol. 61,5 (2019): 783-795. doi:10.1002/dev.21821

Freimer, Daniel et al. “The gut microbiota, HPA axis, and brain in adolescent-onset depression: Probiotics as a novel treatment.” Brain, behavior, & immunity – health vol. 26 100541. 29 Oct. 2022, doi:10.1016/j.bbih.2022.100541

Hathaway, Elizabeth E et al. “Antidepressant Treatment Duration in Pediatric Depressive and Anxiety Disorders: How Long is Long Enough?.” Current problems in pediatric and adolescent health care vol. 48,2 (2018): 31-39. doi:10.1016/j.cppeds.2017.12.002

Kato-Kataoka, A et al. “Fermented milk containing Lactobacillus casei strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress.” Beneficial microbes vol. 7,2 (2016): 153-6. doi:10.3920/BM2015.0100

Li, Yumei, and Sylvia Y C L Kwok. “A Longitudinal Network Analysis of the Interactions of Risk and Protective Factors for Suicidal Potential in Early Adolescents.” Journal of youth and adolescence vol. 52,2 (2023): 306-318. doi:10.1007/s10964-022-01698-y

Liu, Lanxiang et al. “Gut microbiota and its metabolites in depression: from pathogenesis to treatment.” EBioMedicine vol. 90 (2023): 104527. doi:10.1016/j.ebiom.2023.104527

Liu, Lanxiang et al. “Toward a Deeper Understanding of Gut Microbiome in Depression: The Promise of Clinical Applicability.” Advanced science (Weinheim, Baden-Wurttemberg, Germany) vol. 9,35 (2022): e2203707. doi:10.1002/advs.202203707

Maile Combs and David Despain. “Microbes for Mental Health.” International Probiotics Association, 21 Feb. 2023, International Probiotics Association, https://internationalprobiotics.org/home/microbes-for-mental-health/.

Mayne, Stephanie L et al. “COVID-19 and Adolescent Depression and Suicide Risk Screening Outcomes.” Pediatrics vol. 148,3 (2021): e2021051507. doi:10.1542/peds.2021-051507

McEwen, Bruce S et al. “Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex.” Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 41,1 (2016): 3-23. doi:10.1038/npp.2015.171

McVey Neufeld, Karen-Anne et al. “Reframing the Teenage Wasteland: Adolescent Microbiota-Gut-Brain Axis.” Canadian journal of psychiatry. Revue canadienne de psychiatrie vol. 61,4 (2016): 214-21. doi:10.1177/0706743716635536

Pfeifer, Jennifer H et al. “Entering adolescence: resistance to peer influence, risky behavior, and neural changes in emotion reactivity.” Neuron vol. 69,5 (2011): 1029-36. doi:10.1016/j.neuron.2011.02.019

Ramadan, Yasmin N et al. “Microbiome Gut-Brain-Axis: Impact on Brain Development and Mental Health.” Molecular neurobiology, 10.1007/s12035-025-04846-0. 15 Apr. 2025, doi:10.1007/s12035-025-04846-0

Raymond, Catherine et al. “Early childhood adversity and HPA axis activity in adulthood:The importance of considering minimal age at exposure.” Psychoneuroendocrinology vol. 124 (2021): 105042. doi:10.1016/j.psyneuen.2020.105042

Sarkar, Amar et al. “The role of the microbiome in the neurobiology of social behaviour.” Biological reviews of the Cambridge Philosophical Society vol. 95,5 (2020): 1131-1166. doi:10.1111/brv.12603

Sawada, Daisuke, et al. “Daily intake of Lactobacillus gasseri CP2305 improves mental, physical, and sleep quality among Japanese medical students enrolled in a cadaver dissection course.” Journal of Functional Foods 31 (2017): 188-197.

Shaw, Gladys A et al. “Adolescent maturation of the prefrontal cortex: Role of stress and sex in shaping adult risk for compromise.” Genes, brain, and behavior vol. 19,3 (2020): e12626. doi:10.1111/gbb.12626

Teng, Teng et al. “Microbiota alterations leading to amino acid deficiency contribute to depression in children and adolescents.” Microbiome vol. 13,1 128. 19 May. 2025, doi:10.1186/s40168-025-02122-w

Thapar, Anita, and Lucy Riglin. “The importance of a developmental perspective in Psychiatry: what do recent genetic-epidemiological findings show?.” Molecular psychiatry vol. 25,8 (2020): 1631-1639. doi:10.1038/s41380-020-0648-1

Tremblay, Annie et al. “The effects of psychobiotics on the microbiota-gut-brain axis in early-life stress and neuropsychiatric disorders.” Progress in neuro-psychopharmacology & biological psychiatry vol. 105 (2021): 110142. doi:10.1016/j.pnpbp.2020.110142

Wilson, Debra Rose et al. “The Gut Microbiome and Mental Health.” Journal of holistic nursing : official journal of the American Holistic Nurses’ Association vol. 42,1 (2024): 79-87. doi:10.1177/08980101231170487